StonvexLoading…
StonvexStonvexStonvexCore line items from CCC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.06B | $944.80M | $866.38M | $782.45M |
Operating Income | $93.84M | $80.11M | $-23.93M | $51.92M |
Net Income | $1.69M | $31.24M | $-90.07M | $38.41M |
EPS (Diluted) | $0.00 | $0.04 | $-0.15 | $0.06 |
Total Assets | $3.57B | $3.18B | $3.05B | $3.35B |
Total Liabilities | $1.79B | $1.16B | $1.25B | $1.29B |
Cash & Equivalents | $111.19M | $398.98M | $195.57M | $323.79M |
Free Cash Flow OCF − CapEx | $254.51M | $230.87M | $195.00M | $151.96M |
Shares Outstanding | 605.45M | 629.21M | 603.13M | 622.07M |